About Y+L amino acid transporter 1
Y+L amino acid transporter 1 (SLC7A7) is a protein
from Homo sapiens identified by UniProt accession
Q9UM01, 511 residues long.
MolForge cross-references it against 0 known binders and
142 disease associations.
Target properties
| Protein name | Y+L amino acid transporter 1 |
| UniProt accession | Q9UM01 |
| Gene | SLC7A7 |
| Organism | Homo sapiens |
| Length | 511 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (142)
Diseases linked to this target (Open Targets).
- lysinuric protein intolerance · score 0.85
- autoinflammatory syndrome · score 0.41
- Sensorineural hearing impairment · score 0.37
- HbA1c measurement · score 0.33
- type 2 diabetes mellitus · score 0.27
- heart failure · score 0.23
- genetic disorder · score 0.19
- glioblastoma multiforme · score 0.19
- breast adenocarcinoma · score 0.18
- obese body mass index status · score 0.17
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9UM01-F1 | alphafold | PREDICTED | 83.80 | — |
Amino-acid sequence (511 residues)
MVDSTEYEVA SQPEVETSPL GDGASPGPEQ VKLKKEISLL NGVCLIVGNM IGSGIFVSPK GVLIYSASFG LSLVIWAVGG LFSVFGALCY AELGTTIKKS GASYAYILEA FGGFLAFIRL WTSLLIIEPT SQAIIAITFA NYMVQPLFPS CFAPYAASRL LAAACICLLT FINCAYVKWG TLVQDIFTYA KVLALIAVIV AGIVRLGQGA STHFENSFEG SSFAVGDIAL ALYSALFSYS GWDTLNYVTE EIKNPERNLP LSIGISMPIV TIIYILTNVA YYTVLDMRDI LASDAVAVTF ADQIFGIFNW IIPLSVALSC FGGLNASIVA ASRLFFVGSR EGHLPDAICM IHVERFTPVP SLLFNGIMAL IYLCVEDIFQ LINYYSFSYW FFVGLSIVGQ LYLRWKEPDR PRPLKLSVFF PIVFCLCTIF LVAVPLYSDT INSLIGIAIA LSGLPFYFLI IRVPEHKRPL YLRRIVGSAT RYLQVLCMSV AAEMDLEDGG EMPKQRDPKS N
Explore Y+L amino acid transporter 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets